Home Merck Animal Health Announces USDA Approval of Innovative Canine Flu Bivalent Vaccine
 

Keywords :   


Merck Animal Health Announces USDA Approval of Innovative Canine Flu Bivalent Vaccine

2016-10-07 22:05:00| Merck.com - Corporate News

Dateline City: MADISON, N.J. First Vaccine to Offer Protection Against Both Strains of Canine Influenza MADISON, N.J.--(BUSINESS WIRE)--Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, today announced that the U.S. Department of Agriculture has approved a license for Nobivac Canine Flu Bivalent vaccine the first vaccine to aid in the control of disease associated with both canine influenza virus (CIV) H3N2 and canine influenza virus H3N8. Language: English Contact: MerckMedia:Kelly Goss, 913-558-6452 kelly.goss@merck.com orPamela Eisele, 267-305-3558 pamela.eisele@merck.com orInvestor Relations:Amy Klug, 908-740-1898 amy.klug@merck.com Ticker Slug: Ticker: MRK Exchange: NYSE read more

Tags: health animal approval innovative

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
02.11Subtropical Storm Patty Update Statement
02.11Summary for Subtropical Storm Patty (AT2/AL172024)
02.11Atlantic Tropical Weather Outlook
02.11Eastern North Pacific Tropical Weather Outlook
02.11Weekly Recap: Nippon Paint, AkzoNobel, PPG Top This Weeks Stories
02.11Subtropical Storm Patty Graphics
02.11Subtropical Storm Patty Forecast Discussion Number 1
02.11Subtropical Storm Patty Wind Speed Probabilities Number 1
More »